Indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (coagulase positive staphylococci, Pseudomonas aeruginosa and Enterococcus faecalis).
Features and benefits:
Novel triazole antifungal, new to animal health
Particularly effective against Malassezia pachydermatis
More potent than other veterinary antifungals
Broad spectrum antibiotic
Proven efficacy against bacteria associated with canine otitis externa including Pseudomonas aeruginosa
High local concentrations minimize risk of microbial resistance
Mometasone furoate monohydrate:
Potent anti-inflammatory agent
Good margin of adrenal safety
No adrenocortical suppression at 3 times recommended dose for 21 days
Revision date indicates the date the MSDS or SDS was last revised. MSDS / SDS are
dated when they are originally issued AND when any significant change has been made
to the chemical compound or research has revealed a health or physical hazard different
from what was originally stated.